X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Guest Post: The importance of a modern FDA in drug discovery

By Guest Contributor  |    March 22, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Exploring the new era of medicine

By Bill Chin, M.D.  |    February 21, 2017
We are in a new era of medicine where innovations are transforming our ability to attack the cause of disease, not just the symptoms. Where treatment decisions are increasingly focused on the...   Read More

Guest Post: Johnson and Johnson is celebrating outstanding scientists: Who will be next?

By Guest Contributor  |    February 15, 2017
As a health care company with the mission of bringing forward transformational solutions for patients and consumers, innovative scientific advances are the essence of our success. We believe that...   Read More

Watch: Biomarkers in drug development with Dr. Bernie Zeiher

By Andrew Powaleny  |    February 14, 2017
Biomarkers are powerful tools which are used by medical professionals in many ways, including in the diagnosis of disease, monitoring how a disease is progressing and, if a treatment is given, how...   Read More

Video: Translating science into new medicines

By Andrew Powaleny  |    December 12, 2016
Researchers and scientists at America’s biopharmaceutical companies and around the globe work every day to translate science into new treatments and cures to allow patients to live longer,...   Read More

ICYMI: More than 60 PhRMA company scientists visit Capitol Hill

By Andrew Powaleny  |    September 30, 2016
Last week, PhRMA brought more than 60 member company researchers and scientists to Capitol Hill for a biopharmaceutical researcher fly-in. The fly-in highlighted the important science that’s...   Read More

Targeting the immune system, not the tumor

By Andrew Powaleny  |    April 14, 2016
One of the most exciting areas of cancer research today is immuno-oncology. Immuno-oncology is based on the concept of harnessing the body’s own immune system to fight cancer, and while it’s an...   Read More

A voice for patients

By Guest Contributor  |    April 11, 2016
Dr. Michael Rosenblatt, Executive Vice President and Chief Medical Officer - Merck  I didn’t grow up thinking I wanted to become a chief medical officer (CMO), but at a young age, my love of...   Read More

America’s biopharmaceutical industry is central to diverse R&D ecosystem

By Andrew Powaleny  |    March 29, 2016
America’s biopharmaceutical companies are at the heart of a robust research and development (R&D) ecosystem that supports continued medical advances for patients. This includes small and large...   Read More

Research doesn’t end on a medicine’s approval

By Andrew Powaleny  |    March 16, 2016
Research is a critical part of the development of new medicines, but it doesn’t stop once the medicine is approved by the U.S. Food and Drug Administration (FDA).  In fact, that’s when...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates